NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | 15.00K |
| Gross Profit | -- | -- | -- | -- | -15.00K |
| SG&A Expenses | 18.11M | 17.07M | 15.26M | 14.08M | 10.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.30M | 31.41M | 30.57M | 29.74M | 26.57M |
| Operating Income | -31.30M | -31.41M | -30.57M | -29.74M | -26.57M |
| Income Before Tax | -48.47M | -88.25M | -80.01M | -82.95M | -56.29M |
| Income Tax Expenses | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Earnings from Continuing Operations | -48.48 | -88.25 | -80.01 | -82.95 | -56.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.48M | -88.25M | -80.01M | -82.95M | -56.30M |
| EBIT | -31.30M | -31.41M | -30.57M | -29.74M | -26.57M |
| EBITDA | -30.11M | -30.22M | -29.37M | -28.54M | -25.36M |
| EPS Basic | -2.23 | -4.94 | -4.86 | -5.24 | -4.61 |
| Normalized Basic EPS | -2.01 | -3.27 | -2.89 | -3.14 | -2.74 |
| EPS Diluted | -2.31 | -4.94 | -4.86 | -5.24 | -4.61 |
| Normalized Diluted EPS | -1.95 | -3.27 | -2.89 | -3.14 | -2.74 |
| Average Basic Shares Outstanding | 96.92M | 81.18M | 70.33M | 61.71M | 47.56M |
| Average Diluted Shares Outstanding | 109.12M | 81.18M | 70.33M | 61.71M | 47.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |